Videos

Three-time cancer survivor and one-woman show writer and performer, Valerie David, sat down with CURE® to discuss life as a survivor.

The legendary broadcast journalist Katie Couric sat down with CURE® to discuss her advocacy work in increasing cancer awareness with Stand Up To Cancer.

With new ways to treat chemotherapy-induced side effects, it seems that chemotherapy, combined with checkpoint inhibitors, is here to stay for the foreseeable future, according to one expert.

One expert weighs the benefits and drawbacks of expanding clinical trials to be more inclusive and reflective of the general patient population with cancer.

Former NFL player Rolf Benirschke spoke to CURE® about his life-changing diagnosis and offers advice and encouragement to patients coping with a diagnosis of any kind.

Katie Couric discussed the many challenges she faced while being a caregiver to her husband during his nine-month battle with colorectal cancer and shared how her career helped her to cope with the loss and turmoil in her life.

Studies show that the social stigma can actually affect a patient’s level of care and lead to worse health outcomes.

Tumor mutation burden may be an independent predictor of developing depression in patients with lung cancer, according to Dr. Daniel McFarland.

Katie Couric spoke about the challenges she faced while caring for her late husband while maintaining a career and taking care of her daughters’ needs during their family’s unfortunate circumstances.

Breakthroughs such as CAR-T cell therapy in the treatment of mantle cell lymphoma could help patients overcome drug resistance and ultimately live longer, according to Dr. Michael Wang.

Trilaciclib, an intravenous CDK 4/6 inhibitor, in combination with Hycamtin may reduce chemotherapy-induced myelosuppression in small cell lung cancer, according to one expert.

Discussing a parent’s cancer diagnosis with children can be difficult and the conversation changes as they get older. Here’s how the broadcast journalist broached the delicate situation through her own experience.

Mantle cell lymphoma remains incurable, despite researchers’ best efforts. However, new treatment options show promise in the relapsed/refractory setting and may improve patient outcomes if moved to the front-line, according to Dr. Reem Karmali.

With so many cancer treatment options now available, clinicians may still fall short in understanding what’s important to patients.